Sun Pharmaceuticals reported INR74.5B in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Aspen Pharmacare APN:SJ 15.58B 468M
Bharat Petroleum BPCL:IN 982.74B 118.84B
Cipla CIPLA:IN 45.47B 24.7M
Dr.Reddys Laboratories DRRD:IN 47.21B 2.27B
Jiangsu Hengrui Me. 600276:CH 5.06B 113.59M
Reliance Infra RELI:IN 1553.14B 274.27B
Sh Fosun Pharma 600196:CH 8.72B 2B
Sun Pharmaceuticals SUNP:IN IR 74500.1M 6618.2M
UPL UPLL:IN 91.28B 18.62B